Drug Profile
Anti-D Rho immunoglobulin - Mitsubishi Tanabe
Alternative Names: Anti-D Human Immunoglobulin; Dry anti-Rho(D) immune human globulinLatest Information Update: 25 May 2011
Price :
$50
*
At a glance
- Originator Mitsubishi Tanabe Pharma Corporation
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunoglobulin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemolytic disease of newborn